Company intelligence / Profile preview
Verismo Therapeutics
Philadelphia, Pennsylvania, United Statesverismotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Phase 1
01
Overview
Verismo Therapeutics has advanced its proprietary KIR-CAR T-cell therapy into Phase 1 clinical trials. The company’s approach aims to overcome the limitations of traditional single-chain CAR T therapies—such as T-cell exhaustion and limited efficacy in solid tumors—by using a multi-chain immunoreceptor design inspired by NK cell biology. Early preclinical data demonstrated reduced exhaustion and improved tumor killing; current clinical results are pending as both lead programs are in early-stage human studies.
- Therapeutic areas
- Oncology
- Modalities
- CAR T-cell therapy (specifically KIR-CAR platform)
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →03
Partnerships
University of Pennsylvania – technology originator, research collaboration, IP licensing partner. Penn holds equity interests in parent company HLB Innovation.
Beyond the preview
Go deeper on Verismo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Verismo Therapeutics.